Twist Bioscience Corp Q3 2026 Profitability Outlook

Market overview

Derived from Twist Bioscience Corp (TWST) (CIK 0001581280) 10-Q filing analysis

FINANCIAL prediction market

Implied probability (Yes)

60%

Closes

2026-05-26

More FINANCIAL markets

• NAV per Share Growth — 75% Yes
• Filing of 2026 Annual Report — 85% Yes
• Navan, Inc. Revenue Growth Projection — 75% Yes
• SPRU Annual Revenue Growth — 65% Yes
• GS Mortgage Securities Trust 2028-GSA3 - Continued Filing Compliance — 85% Yes
• Twist Bioscience Corp Q3 2026 Revenue Analysis — 75% Yes
• Net Written Premium Growth in 2026 — 75% Yes
• Stereotaxis, Inc. Operating Cash Flow Stability — 60% Yes

Browse all FINANCIAL markets →